Bactiguard Holding AB (OSTO:BACTI B) Notes Receivable: kr0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BACTI B Bactiguard Holding AB OSTO:BACTI B
61 GF Score
Price kr16.10
GF Value kr30.69
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Bactiguard Holding AB Notes Receivable?

Bactiguard Holding AB OSTO:BACTI B -2.72% 61 Notes Receivable is kr0.0 Mil as of Jun. 2026. GuruFocus rates OSTO:BACTI B with a GF Score™ of 61/100 and a GF Value™ of kr30.69 (Possible Value Trap). The stock has 2 warning signs investors should review.

Bactiguard Holding AB's Notes Receivable for the quarter that ended in Jun. 2026 was kr0.0 Mil.


Bactiguard Holding AB Notes Receivable Related Terms


Bactiguard Holding AB Notes Receivable Historical Data

* Premium members only.

The historical data trend for Bactiguard Holding AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bactiguard Holding AB Notes Receivable Chart

Bactiguard Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bactiguard Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:BACTI B
61GF Score
Bactiguard Holding AB OSTO:BACTI B
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bactiguard Holding AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0.0 Mil mean?
Bactiguard Holding AB (OSTO:BACTI B) has a Notes Receivable of kr0.0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bactiguard Holding AB and its competitors.
Is Bactiguard Holding AB's Notes Receivable too high?
Bactiguard Holding AB's current Notes Receivable is kr0.0 Mil. Overall, Bactiguard Holding AB has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Notes Receivable compare to ABT and SYK?
Bactiguard Holding AB's Notes Receivable of kr0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current Notes Receivable is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bactiguard Holding AB (OSTO:BACTI B) is currently considered Possible Value Trap. The stock's GF Value™ is kr30.69, compared to a current price of kr16.10 — trading 47.5% below its estimated fair value. The current Notes Receivable is kr0.0 Mil. Bactiguard Holding AB's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Bactiguard Holding AB (OSTO:BACTI B), the current Notes Receivable is kr0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bactiguard Holding AB (OSTO:BACTI B) Overvalued in 2026?

Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued. The current stock price of kr16.10 is trading 47.5% below its estimated GF Value™ of kr30.69. GuruFocus considers Bactiguard Holding AB to be Possible Value Trap.

Key valuation signals for OSTO:BACTI B:

  • Notes Receivable: kr0.0 Mil
  • GF Value™: kr30.69 vs. price of kr16.10 (47.5% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the OSTO:BACTI B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bactiguard Holding AB Business Description

Other Exchanges 5JE:Germany
Address Vasagatan 11, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
61GF Score

Get the complete analysis for OSTO:BACTI B

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr16.10
Price
kr30.69
GF Value